Cancer HealthCast: NCI Program Unlocks Emerging Proteomic Data to Advance Precision Medicine
Researchers say sharing molecular cancer research data can expand cancer treatment and care.
Proteomics is an emerging field in cancer care and research. The National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) aims to get to the heart of cancer by studying its molecular basis across different cancers. The group believes expanding open-source resources and other data can lead to new treatments in cancer and expand precision medicine.
Dr. Henry Rodriguez, the founding director of the Office of Cancer Clinical Proteomics Research at NCI, discusses the program and how the related International Cancer Proteogenome Consortium (ICPC) is helping researchers pull together resources necessary to innovate cancer care.
-
Dr. Henry Rodriguez Founding Director, Office of Cancer Clinical Proteomics Research NCI
-
Equipping the Federal Workforce for AI
Federal leaders discuss advancing AI talent development through upskilling, partnerships and responsible adoption.
20m watch -
Pentagon Memo Creates Unified Tech Enterprise for Acquisition Modernization
War Secretary names Emil Michael "single CTO" in charge of a consolidated defense innovation portfolio as the department builds a single operating system for modernization.
5m read -
Navy Embraces New Risk Posture to Speed Tech Delivery
As global threats intensify, leaders push cultural and structural reforms to accelerate software and data capabilities at the edge.
19m watch Partner Content -
Congressional Spending Deal Could Revive Technology Modernization Fund
A $1.2 trillion minibus would extend the TMF through Sept. 30, unlocking nearly $200 million and preserving momentum for federal modernization projects.
2m read
